709 related articles for article (PubMed ID: 26965148)
1. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.
Iannotti FA; Di Marzo V; Petrosino S
Prog Lipid Res; 2016 Apr; 62():107-28. PubMed ID: 26965148
[TBL] [Abstract][Full Text] [Related]
2. G protein coupled receptor 18: A potential role for endocannabinoid signaling in metabolic dysfunction.
Rajaraman G; Simcocks A; Hryciw DH; Hutchinson DS; McAinch AJ
Mol Nutr Food Res; 2016 Jan; 60(1):92-102. PubMed ID: 26337420
[TBL] [Abstract][Full Text] [Related]
3. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
Pertwee RG
Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
[TBL] [Abstract][Full Text] [Related]
4. An Introduction to the Endogenous Cannabinoid System.
Lu HC; Mackie K
Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion.
Quartu M; Poddighe L; Melis T; Serra MP; Boi M; Lisai S; Carta G; Murru E; Muredda L; Collu M; Banni S
Lipids Health Dis; 2017 Jan; 16(1):14. PubMed ID: 28103941
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
Gertsch J
Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
[TBL] [Abstract][Full Text] [Related]
7. Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.
Turcotte C; Chouinard F; Lefebvre JS; Flamand N
J Leukoc Biol; 2015 Jun; 97(6):1049-70. PubMed ID: 25877930
[TBL] [Abstract][Full Text] [Related]
8. Why do cannabinoid receptors have more than one endogenous ligand?
Di Marzo V; De Petrocellis L
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid biosynthesis and inactivation, from simple to complex.
Muccioli GG
Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system.
Kilaru A; Chapman KD
Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid system and pain: an introduction.
Burston JJ; Woodhams SG
Proc Nutr Soc; 2014 Feb; 73(1):106-17. PubMed ID: 24148358
[TBL] [Abstract][Full Text] [Related]
12. Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood.
Banni S; Di Marzo V
Mol Nutr Food Res; 2010 Jan; 54(1):82-92. PubMed ID: 20013888
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids in nervous system health and disease: the big picture in a nutshell.
Skaper SD; Di Marzo V
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3193-200. PubMed ID: 23108539
[TBL] [Abstract][Full Text] [Related]
14. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
15. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system: Overview of an emerging multi-faceted therapeutic target.
Chanda D; Neumann D; Glatz JFC
Prostaglandins Leukot Essent Fatty Acids; 2019 Jan; 140():51-56. PubMed ID: 30553404
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
[TBL] [Abstract][Full Text] [Related]
18. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the endocannabinoid system by lipid rafts.
Dainese E; Oddi S; Bari M; Maccarrone M
Curr Med Chem; 2007; 14(25):2702-15. PubMed ID: 17979719
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs.
Di Marzo V; De Petrocellis L
Curr Med Chem; 2010; 17(14):1430-49. PubMed ID: 20166923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
